<> "The repository administrator has not yet configured an RDF license."^^ . <> . . . "POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME"^^ . "Hepatorenal syndrome (HRS) is a severe complication that occurs in patients with cirrhosis of the liver (LC), characterized by clinical manifestations of renal failure (RF). Type 2 HRS is observed in patients with severe ascites that are refractory to diuretics. The average survival time of patients with type 2 HRS is 6 months. The laboratory criteria for type 2 HRS are the level of creatinine in the blood serum (above 150 mmol/l), characterized by a high plasma content of renin, aldosterone and antidiuretic hormone. Kidney failure develops slowly ."^^ . "2025-01-22" . . "2" . "1" . . "INTERNATIONAL CONFERENCE OF NATURAL AND SOCIAL-HUMANITARIAN SCIENCES"^^ . . . . . . . . . . "Jumayeva M.F."^^ . "Jumayeva M.F."^^ . "Jumayeva M.F. Jumayeva M.F."^^ . . "Ahmedova N.Sh."^^ . "Ahmedova N.Sh."^^ . "Ahmedova N.Sh. Ahmedova N.Sh."^^ . . . . . . "POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME (PDF)"^^ . . . . . "9-10_Jumayeva.pdf"^^ . . "HTML Summary of #99120 \n\nPOSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME\n\n" . "text/html" . .